id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-286368-kdwh4hgf	Hui, David S.C.	A clinical approach to the threat of emerging influenza viruses in the Asia‐Pacific region	2017-07-05		.txt	text/plain	7703	432	44	Observational studies have shown that treatment with a neuraminidase inhibitor (NAI) for adults hospitalized with severe influenza is associated with lower mortality and better clinical outcomes, especially when administered early in the course of illness. The global circulation of oseltamivir-resistant seasonal influenza, the emergence of A(H1N1)pdm09 virus in 2009 followed by its continual circulation, 6 the rising number of A(H7N9) infections in humans 2 and the ongoing spread of A(H5N8) in recent months in the poultry populations in many countries in Asia, Africa, Europe and Middle East with pandemic potential 7 all point to an urgent need for developing more effective antiviral therapies to reduce morbidity and mortality. Human infections with a novel avian influenza A (H7N9) virus were first reported in China in March 2013 in patients hospitalized with severe pneumonia.	./cache/cord-286368-kdwh4hgf.txt	./txt/cord-286368-kdwh4hgf.txt